» Articles » PMID: 35401201

Potential Natural Small Molecular Compounds for the Treatment of Chronic Obstructive Pulmonary Disease: An Overview

Overview
Journal Front Pharmacol
Date 2022 Apr 11
PMID 35401201
Authors
Affiliations
Soon will be listed here.
Abstract

Chronic obstructive pulmonary disease (COPD) is one of the major diseases threatening human life and health. According to the report released by the World Health Organization (WHO) in 2020, COPD has become the third leading cause of death in the world, featuring a sustainable growth of incidence rate as well as population age. The purpose of this review focuses on the advancement of bioactive natural compounds, such as baicalin, quercetin, resveratrol, and curcumin, which demonstrate promising therapeutic/interventional effects on CODP and . Information emphasizing on COPD was systematically collected from several authoritative internet databases including Web of Science, PubMed, Elsevier, Wiley Online Library, and Europe PMC, with a combination of keywords containing "COPD" and "natural small molecular compounds". The new evidence indicated that these valuable molecules featured unique functions in the treatment of COPD through various biological processes such as anti-inflammatory, anti-oxidant, anti-apoptosis, and anti-airway fibrosis. Moreover, we found that the promising effects of these natural compounds on COPD were mainly achieved through JAK3/STAT3/NF-κB and MAPK inflammatory signaling pathways, Nrf2 oxidative stress signaling pathway, and TGF-β1/Smad 2/3 fibrosis signaling pathway, which referenced to multiple targets like TNF-α, IL-6, IL-8, TIMP-1, MMP, AKT, JAK3, IKK, PI3K, HO-1, MAPK, P38, ERK, etc. Current challenges and future directions in this promising field are also discussed at the end of this review. For the convenience of the readers, this review is divided into ten parts according to the structures of potential natural small molecular compounds. We hope that this review brings a quick look and provides some inspiration for the research of COPD.

Citing Articles

Mitigating inflammation and fibrosis: the therapeutic potential of quercetin liposomes in COPD.

Yin C, Tian Y, Yan A, Wang H, Lu F, Li X Front Pharmacol. 2025; 15:1503283.

PMID: 39741632 PMC: 11685140. DOI: 10.3389/fphar.2024.1503283.


Screening COPD-Related Biomarkers and Traditional Chinese Medicine Prediction Based on Bioinformatics and Machine Learning.

Cao Z, Zhao S, Hu S, Wu T, Sun F, Shi L Int J Chron Obstruct Pulmon Dis. 2024; 19:2073-2095.

PMID: 39346628 PMC: 11438478. DOI: 10.2147/COPD.S476808.


Effect of allyl isothiocyanate on 4-HNE induced glucocorticoid resistance in COPD and the underlying mechanism.

Chang W, Wang M, Zhu W, Dai T, Han Z, Sun N Heliyon. 2024; 10(17):e37275.

PMID: 39296102 PMC: 11408060. DOI: 10.1016/j.heliyon.2024.e37275.


Natural small molecules synergize mesenchymal stem cells for injury repair in vital organs: a comprehensive review.

Qu Y, Wang Z, Dong L, Zhang D, Shang F, Li A Stem Cell Res Ther. 2024; 15(1):243.

PMID: 39113141 PMC: 11304890. DOI: 10.1186/s13287-024-03856-4.


Protective effect of the total alkaloid extract from Bulbus on cigarette smoke-induced Beas-2B cell injury model and transcriptomic analysis.

Wang X, Liu X, Aga E, Tse W, Tse K, Ye B Food Nutr Res. 2024; 68.

PMID: 38974914 PMC: 11227262. DOI: 10.29219/fnr.v68.10689.


References
1.
Lee H, Jung K, Lee H, Park S, Choi W, Bae H . Casticin, an active compound isolated from Vitex Fructus, ameliorates the cigarette smoke-induced acute lung inflammatory response in a murine model. Int Immunopharmacol. 2015; 28(2):1097-101. DOI: 10.1016/j.intimp.2015.07.041. View

2.
Jung K, Beak H, Park S, Shin D, Jung J, Park S . The therapeutic effects of tuberostemonine against cigarette smoke-induced acute lung inflammation in mice. Eur J Pharmacol. 2016; 774:80-6. DOI: 10.1016/j.ejphar.2016.02.006. View

3.
Liu W, Tan X, Shu L, Sun H, Song J, Jin P . Ursolic acid inhibits cigarette smoke extract-induced human bronchial epithelial cell injury and prevents development of lung cancer. Molecules. 2012; 17(8):9104-15. PMC: 6268827. DOI: 10.3390/molecules17089104. View

4.
Cheng L, Li F, Ma R, Hu X . Forsythiaside inhibits cigarette smoke-induced lung inflammation by activation of Nrf2 and inhibition of NF-κB. Int Immunopharmacol. 2015; 28(1):494-9. DOI: 10.1016/j.intimp.2015.07.011. View

5.
Zhang M, Tang J, Li Y, Xie Y, Shan H, Chen M . Curcumin attenuates skeletal muscle mitochondrial impairment in COPD rats: PGC-1α/SIRT3 pathway involved. Chem Biol Interact. 2017; 277:168-175. DOI: 10.1016/j.cbi.2017.09.018. View